[1]
B. P. Rodriguez Arroyo, A. Mondragón-Cardona, R. A. Pacheco-Orozco, A. Tamayo, J. C. Moreno, and J. C. Baena-Valencia, “Partial response to treatment with ALK inhibitor in a patient with SQSTM1-ALK fusion positive lung adenocarcinoma”, EJCRIM, vol. 11, no. 12, Nov. 2024, doi: 10.12890/2024_004887.